Landos Biopharma OverviewLandos Biopharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for LABP.
Quarterly EBIT
-$9.30M
↓ 43.46% YoY
As of Mar 31, 2024
Annual EBIT (TTM)
-$25.20M
↑ 20.02% YoY
Trailing 12 months ending Mar 31, 2024
Landos Biopharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for LABP.
As of Mar 31, 2024
Trailing 12 months ending Mar 31, 2024